Ngā hua rapu - Shuji Shirotori
- E whakaatu ana i te 1 - 1 hua o te 1
-
1
E7050: A dual c‐Met and VEGFR‐2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models mā Takayuki Nakagawa, Osamu Tohyama, Atsumi Yamaguchi, Tomohiro Matsushima, Keiko Takahashi, Setsuo Funasaka, Shuji Shirotori, Makoto Asada, Hiroshi Obaishi
I whakaputaina 2009Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Angiogenesis
Biology
Biotechnology
C-Met
Cancer
Cancer research
Hepatocyte growth factor
In vivo
Internal medicine
Kinase insert domain receptor
Medicine
Metastasis
Neovascularization
Receptor
Receptor tyrosine kinase
Tumor cells
Tumor microenvironment
Tumor progression
Tyrosine kinase
Tyrosine-kinase inhibitor
VEGF receptors
Vascular endothelial growth factor
Vascular endothelial growth factor A